Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
BRTX
BRTX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
BRTX News
Zevra Therapeutics Reports Strong Q4 Earnings, Shares Surge
1h ago
Benzinga
BioRestorative Secures Patent Protection in Australia
Feb 24 2026
Newsfilter
BioRestorative Closes Public Offering of 14.29 Million Shares
Feb 14 2026
Yahoo Finance
BioRestorative Closes $5 Million Public Offering of 14.3 Million Shares
Feb 14 2026
Newsfilter
U.S. Stocks Decline Midway, Nasdaq Drops Over 350 Points
Feb 12 2026
Benzinga
U.S. Stocks Mostly Higher in Morning Trade, Dow Up Over 200 Points
Feb 12 2026
Benzinga
Fastly Reports Strong Quarterly Earnings Exceeding Expectations
Feb 12 2026
Benzinga
BioRestorative Therapies Prices Public Offering
Feb 12 2026
seekingalpha
BioRestorative Announces Pricing of Public Offering
Feb 12 2026
Newsfilter
BioRestorative Advances FDA Meeting for BRTX-100 Approval Pathway
Feb 11 2026
Newsfilter
Credo Technology Raises Revenue Guidance Significantly
Feb 10 2026
Benzinga
Novo Nordisk (NVO) Gains 9.48% After FDA Approves Wegovy Obesity Pill
Dec 23 2025
NASDAQ.COM
NOTV and APLT Top After-Hours Biotech Gains; ALMS, TELA, CORT, and BRTX Also Show Progress
Nov 18 2025
NASDAQ.COM
Transcript of BioRestorative (BRTX) Earnings Call
Nov 13 2025
NASDAQ.COM
Biorestorative Therapies, Inc. (BRTX) Announces Q3 Loss and Falls Short of Revenue Projections
Nov 13 2025
NASDAQ.COM
Biotech Update: IFRX, ABCL, RLYB Stand Out as Significant Gainers After Hours
Nov 10 2025
NASDAQ.COM
Show More News
